A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, randomized trial to study therapeutic drug monitoring
(TDM) of voriconazole among patients with an invasive mould infection (IMI). The primary
objective of this study will be to assess the effect of prospective voriconazole TDM on the
composite of adverse events (AE) and clinical response.